House Bill 2557
115th Congress(2017-2018)
Prostate Cancer Misdiagnosis Elimination Act of 2017
Introduced
Introduced in House on May 19, 2017
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2557
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Prostate Cancer Misdiagnosis Elimination Act of 2017
This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.
12/06/2017
Placed on the Union Calendar, Calendar No. 331.
12/06/2017
Committee on Ways and Means discharged.
12/06/2017
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-449, Part I.
10/04/2017
Ordered to be Reported (Amended) by Voice Vote.
10/04/2017
Committee Consideration and Mark-up Session Held.
09/13/2017
Forwarded by Subcommittee to Full Committee by Voice Vote .
09/13/2017
Subcommittee Consideration and Mark-up Session Held.
06/01/2017
Referred to the Subcommittee on Health.
05/26/2017
Referred to the Subcommittee on Health.
05/19/2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
05/19/2017
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:36:42 PM